RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $478 | +19.5% | 159,290 | -1.9% | 0.00% | – |
Q2 2023 | $400 | -1.0% | 162,436 | -9.0% | 0.00% | – |
Q1 2023 | $404 | -38.2% | 178,440 | -4.8% | 0.00% | – |
Q4 2022 | $654 | -100.0% | 187,459 | -4.6% | 0.00% | -100.0% |
Q3 2022 | $7,278,000 | +127.1% | 196,556 | +16.5% | 0.00% | – |
Q2 2022 | $3,205,000 | -24.6% | 168,757 | +7.1% | 0.00% | – |
Q1 2022 | $4,253,000 | +1915.6% | 157,565 | +1855.6% | 0.00% | – |
Q3 2021 | $211,000 | -95.8% | 8,057 | -93.8% | 0.00% | -100.0% |
Q4 2019 | $5,049,000 | – | 129,461 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |